1 |
Kazemi MH, Sadri M, Najafi A, Rahimi A, Baghernejadan Z, Khorramdelazad H, Falak R. Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango? Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1018962] [Reference Citation Analysis]
|
2 |
Zhang L, Zhou C, Zhang S, Chen X, Liu J, Xu F, Liang W. Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors. Front Oncol 2022;12:939249. [DOI: 10.3389/fonc.2022.939249] [Reference Citation Analysis]
|
3 |
Nalini R, Roshandel E, Tavakoli Ardakani M, Kazemi M, Gaffari-nazari H, Hajifathali A, Soleimani M. Soluble T Cell Immunoglobulin and Mucin Domain-3 (sTIM-3) Predict Graft-Versus-Host Disease (GVHD) in Iranian Allogeneic Hematopoietic Stem Cell Transplantation. Int J Cancer Manag 2022;15. [DOI: 10.5812/ijcm-120888] [Reference Citation Analysis]
|
4 |
Dunai C, Ames E, Ochoa MC, Fernandez-sendin M, Melero I, Simonetta F, Baker J, Alvarez M. Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment. Adoptive Cell Transfer 2022. [DOI: 10.1016/bs.ircmb.2022.04.001] [Reference Citation Analysis]
|
5 |
Hu LF, Lan HR, Huang D, Li XM, Jin KT. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand? Front Oncol 2021;11:769305. [PMID: 34888246 DOI: 10.3389/fonc.2021.769305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
6 |
Kazemi MH, Momeni-varposhti Z, Roshandel E, Sankanian G, Hosseini Rouzbahani N, Ghorban K, Rajaeinejad M, Hajifathali A. Association of HLA alleles with hematologic malignancies. Gene Reports 2021;25:101346. [DOI: 10.1016/j.genrep.2021.101346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|